Coronavirus Disease 2019-COVID-19

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• Emergence of novel infectious diseases like Ebola, Zika, Nipah, and coronaviruses (CoVs) is a growing global concern.
• A new CoV strain, 2019-nCoV (now SARS-CoV-2), emerged in Wuhan, China, causing coronavirus disease 2019 (COVID-19).
• SARS-CoV-2 is suspected to have a zoonotic origin with human-to-human transmission, though other routes are possible.

Purpose of the Study:

• To provide a comprehensive review of the epidemiological, diagnostic, clinical, and therapeutic aspects of SARS-CoV-2.
• To discuss current and potential preventive measures and therapeutic strategies for COVID-19.
• To compare SARS-CoV-2 with other emerging viral pathogens.

Main Methods:

• Review of existing literature on SARS-CoV-2, COVID-19, and related emerging viral diseases.
• Analysis of epidemiological data, diagnostic methods (real-time PCR, next-generation sequencing), and clinical presentations.
• Evaluation of therapeutic strategies based on previous experiences with SARS-CoV, MERS-CoV, and other viruses.

Main Results:

• SARS-CoV-2 exhibits lower pathogenicity and moderate transmissibility compared to other emerging viruses like Ebola and MERS-CoV.
• Early diagnosis is facilitated by real-time PCR and next-generation sequencing.
• No specific antiviral drugs or vaccines are currently available for SARS-CoV-2, necessitating repurposed therapies.

Conclusions:

• COVID-19 presents a significant public health challenge due to its high transmission competence.
• Understanding the epidemiology, diagnosis, and clinical features of SARS-CoV-2 is crucial for effective management.
• Ongoing research and international collaboration are vital for developing vaccines and effective treatments against SARS-CoV-2.